GenScript Says AI Drug Discovery Business Doubled in First Half

August 19, 2026
GenScript reported first half revenue of about US$404.2 million, up 27.3% year over year, and said its AI enabled drug discovery business doubled from a year earlier.
GenScript Says AI Drug Discovery Business Doubled in First Half

GenScript Biotech Corporation announced in a press release first half revenue of about US$404.2 million on a comparable basis, up 27.3% year over year. Adjusted net profit rose 203.3% to about US$62.5 million.

The company said its AI enabled drug discovery business doubled year over year and continued rapid growth for a third consecutive half year reporting period. GenScript cited demand from AI focused biotechnology companies and pharmaceutical innovators.

GenScript said Gene-to-Protein accounted for about 66% of GenScript Life Science Group revenue. The platform supports discovery, experimental validation, early development, and production support.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

08/19
AssureCare Names Brian Litten EVP of Growth and Commercialization
08/19
DeepCyte Launches DeeTox Atlas for AI Toxicology
08/19
Oracle Health Adds Coding and Dictation to Clinical AI Agent
08/19
Empatica Gets FDA Clearance for Parkinson's Monitoring Platform
08/19
Luma Health and PCC Add AI Communications to Pediatric EHR

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

AI and the Law: Discussion Paper

This discussion paper explores the intersection of artificial intelligence and legal frameworks, addressing potential legal challenges posed by AI's autonomy, adaptiveness, and opacity. It examines issues such as liability gaps, causation, and the potential for granting AI systems legal personality, aiming to foster further discussion on AI's impact on law reform.

Read more

You May Also Like